- Drug maker cutting prices for obesity, diabetes drug The Hill
- Lilly releases Zepbound® (tirzepatide) single-dose vials, expanding supply and access for adults living with obesity Investors | Eli Lilly and Company
- A Popular Weight Loss Drug Is Getting a Price Cut The New York Times
- Zepbound…